Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Kidney Int ; 87(2): 427-33, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24918153

RESUMEN

African Americans with early-onset type 1 diabetes mellitus are at a high risk for severe diabetic nephropathy and end-stage renal disease. In order to determine whether baseline plasma levels of inflammatory markers predict incidence of overt proteinuria or renal failure in African Americans with type 1 diabetes mellitus, we re-examined data of 356 participants in our observational follow-up study of 725 New Jersey African Americans with type 1 diabetes. At baseline and 6-year follow-up, a detailed structured clinical interview was conducted to document medical history including kidney dialysis or transplant, other diabetic complications, and renal-specific mortality. Plasma levels of 28 inflammatory biomarkers were measured using a multiplex bead analysis system. After adjusting for baseline age, glycohemoglobin, and other confounders, the baseline plasma levels of soluble intercellular adhesion molecule-1 (sICAM-1) in the upper two quartiles were, respectively, associated with a three- to fivefold increase in the risk of progression from no albuminuria or microalbuminuria to overt proteinuria. Baseline plasma levels of the chemokine eotaxin in the upper quartile were significantly associated with a sevenfold increase in risk of incident renal failure. These associations were independent of traditional risk factors for progression of diabetic nephropathy. Thus, in type 1 diabetic African Americans, sICAM-1 predicted progression to overt proteinuria and eotaxin-predicted progression to renal failure.


Asunto(s)
Diabetes Mellitus Tipo 1/fisiopatología , Adolescente , Adulto , Negro o Afroamericano , Biomarcadores/sangre , Estudios de Cohortes , Citocinas/sangre , Diabetes Mellitus Tipo 1/complicaciones , Nefropatías Diabéticas/fisiopatología , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Mediadores de Inflamación/sangre , Molécula 1 de Adhesión Intercelular/sangre , Masculino , Persona de Mediana Edad , Proteinuria/fisiopatología , Adulto Joven
2.
Luminescence ; 23(1): 17-21, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18167057

RESUMEN

Screens for compounds and proteins with anti-cancer activity employ viability assays using relevant cancer cell lines. For leukaemia studies, the human leukaemia cell line, HL-60, is often used as a model system. To facilitate the discovery and investigation of anti-leukaemia therapeutics under physiological conditions, we have engineered HL-60 cells that stably express firefly luciferase and produce light that can be detected using an in vivo imaging system (IVIS). Bioluminescent HL-60luc cells could be rapidly detected in whole blood with a sensitivity of approximately 1000 viable cells/200 microl blood. Treatment of HL-60luc cells with the drug chlorambucil revealed that the bioluminescent viability assay is able to detect cell death earlier than the Trypan blue dye exclusion assay. HL-60luc cells administered intraperitoneally (i.p.) or intravenously (i.v.) were visualized in living mice. The rapidity and ease of detecting HL-60luc cells in biological fluid indicates that this cell line could be used in high-throughput screens for the identification of drugs with anti-leukaemia activity under physiological conditions.


Asunto(s)
Antineoplásicos/química , Luciferina de Luciérnaga/química , Leucemia/tratamiento farmacológico , Animales , Antineoplásicos/uso terapéutico , Supervivencia Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Luciferina de Luciérnaga/administración & dosificación , Regulación Enzimológica de la Expresión Génica , Células HL-60 , Humanos , Cinética , Luciferasas de Luciérnaga/química , Luciferasas de Luciérnaga/genética , Luminiscencia , Mediciones Luminiscentes , Ratones , Ratones SCID , Trasplante de Neoplasias , Sensibilidad y Especificidad
3.
Gene ; 388(1-2): 83-92, 2007 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-17116373

RESUMEN

Aggregatibacter actinomycetemcomitans is an oral bacterium that causes localized aggressive periodontitis (LAP) and extra-oral infections such as sub-acute infective endocarditis. As part of its array of virulence factors, A. actinomycetemcomitans produces leukotoxin (LtxA), a member of the RTX family of toxins. LtxA kills human leukocytes and we have recently shown that the toxin is required for beta-hemolysis by A. actinomycetemcomitans on solid medium. In other RTX toxin-producing bacteria, an outer membrane channel-forming protein, TolC, is required for toxin secretion and drug export. We have identified an ORF in A. actinomycetemcomitans that encodes a putative protein having predicted structural properties similar to TolC. Inactivation of this ORF resulted in a mutant that was no longer beta-hemolytic and did not secrete LtxA. This mutant was significantly more sensitive to antimicrobial agents compared to the wild type strain and was unable to export the antimicrobial agent berberine. Thus, this ORF was named tdeA for "toxin and drug export". Examination of the DNA sequence surrounding tdeA revealed two upstream ORFs that encode proteins similar to the drug efflux proteins, MacA and MacB. Inactivation of macB in A. actinomycetemcomitans did not alter the drug sensitivity profile or the hemolytic activity of the mutant. The genes macA, macB and tdeA are organized as an operon and are constitutively expressed as a single transcript. These results show that A. actinomycetemcomitans indeed requires a TolC-like protein for LtxA secretion and that this protein, TdeA, also functions as part of a drug efflux system.


Asunto(s)
Aggregatibacter actinomycetemcomitans/genética , Proteínas Bacterianas/genética , Exotoxinas/metabolismo , Proteínas de Transporte de Membrana/genética , Aggregatibacter actinomycetemcomitans/efectos de los fármacos , Aggregatibacter actinomycetemcomitans/metabolismo , Antibacterianos/metabolismo , Antibacterianos/farmacología , Transporte Biológico/genética , ADN Bacteriano/química , ADN Bacteriano/genética , Farmacorresistencia Bacteriana/genética , Regulación Bacteriana de la Expresión Génica , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Mutación , ARN Bacteriano/genética , ARN Bacteriano/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Análisis de Secuencia de ADN
4.
BMC Dev Biol ; 6: 60, 2006 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-17156430

RESUMEN

BACKGROUND: Cellularization of the Drosophila embryo is an unusually synchronous form of cytokinesis in which polarized membrane extension proceeds in part through incorporation of new membrane via fusion of apically-translocated Golgi-derived vesicles. RESULTS: We describe here involvement of the signaling enzyme Phospholipase D (Pld) in regulation of this developmental step. Functional analysis using gene targeting revealed that cellularization is hindered by the loss of Pld, resulting frequently in early embryonic developmental arrest. Mechanistically, chronic Pld deficiency causes abnormal Golgi structure and secretory vesicle trafficking. CONCLUSION: Our results suggest that Pld functions to promote trafficking of Golgi-derived fusion-competent vesicles during cellularization.


Asunto(s)
Citocinesis , Drosophila melanogaster/citología , Drosophila melanogaster/embriología , Fosfolipasa D/fisiología , Animales , Células COS , Línea Celular , Quimiocina CX3CL1 , Quimiocinas CX3C/análisis , Chlorocebus aethiops , Vesículas Citoplasmáticas/química , Vesículas Citoplasmáticas/enzimología , Vesículas Citoplasmáticas/fisiología , Drosophila melanogaster/genética , Drosophila melanogaster/fisiología , Activación Enzimática , Femenino , Aparato de Golgi/fisiología , Humanos , Masculino , Proteínas de la Membrana/análisis , Membranas/metabolismo , Mutación , Fosfolipasa D/genética , ARN Mensajero Almacenado/metabolismo , Transducción de Señal , Transfección
5.
Diabetes Res Clin Pract ; 114: 117-25, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26806456

RESUMEN

BACKGROUND: To determine whether plasma levels of markers of inflammation are predictive of the incidence of cardiovascular disease (CVD), hypertension, or mortality in African Americans with type 1 diabetes mellitus. METHODS: A total of 484 African Americans with type 1 diabetes were included. At baseline and 6-year follow-up, a clinical interview and examination were conducted to document CVD and systemic hypertension. Venous blood for glycated hemoglobin and cholesterol was obtained and albumin excretion rate measured. Mortality was assessed annually between baseline and 6-year follow-up by review of the social security death index. Baseline plasma levels of 28 inflammatory biomarkers were measured using multiplex bead analysis system. RESULTS: After adjusting for baseline age and other confounders, African Americans with type 1 diabetes in the highest quartile of plasma interferon-inducible protein 10 (IP-10) were three times more likely to develop CVD than those in the lowest quartile. African Americans with type 1 diabetes in the lowest quartiles of plasma stromal derived factor-1 (SDF-1) had a 75% higher risk of death than patients in the highest quartile, independently of age, low density lipoprotein cholesterol, body mass index, hypertension, and albuminuria. CONCLUSION: In African Americans with type 1 diabetes, high plasma IP-10 is an independent predictor for incident CVD and low SDF-1 an independent predictor for mortality.


Asunto(s)
Biomarcadores/sangre , Negro o Afroamericano/estadística & datos numéricos , Enfermedades Cardiovasculares/diagnóstico , Diabetes Mellitus Tipo 1/complicaciones , Inflamación/diagnóstico , Mortalidad/etnología , Adolescente , Adulto , Enfermedades Cardiovasculares/sangre , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/mortalidad , Quimiocina CXCL12/sangre , Colesterol/sangre , LDL-Colesterol/sangre , Diabetes Mellitus Tipo 1/fisiopatología , Femenino , Hemoglobina Glucada/análisis , Humanos , Incidencia , Inflamación/sangre , Inflamación/epidemiología , Inflamación/mortalidad , Interleucina-10/sangre , Masculino , Pronóstico , Factores de Riesgo , Tasa de Supervivencia , Estados Unidos/epidemiología , Adulto Joven
6.
Gene ; 306: 45-55, 2003 Mar 13.
Artículo en Inglés | MEDLINE | ID: mdl-12657466

RESUMEN

The ATP-dependent Lon protease is a multi-functional enzyme that is conserved from archae to mammalian mitochondria, which not only degrades protein substrates but also binds DNA. As a starting point toward understanding Lon function in development, the mouse Lon cDNA was cloned and the encoded protein was characterized in cultured mammalian cells, in yeast and in vitro. Mouse Lon shows 87, 40 and 33% amino acid similarity with the human, yeast and bacterial homologs, respectively. Expression of a single mouse Lon transcript is detected in liver>heart>kidney>testis and is present during early embryonic development. Endogenous as well as transiently overexpressed mouse Lon co-localize with mitochondrial markers and have half-lives greater than 24 h as determined by pulse-chase studies. Enzymatically active mouse Lon that hydrolyses ATP and degrades protein and peptide substrates in an ATP-dependent manner also specifically binds to single-stranded but not to double-stranded DNA oligonucleotides. We propose that binding to TG-rich DNA sequences has been conserved between the mouse and human proteins. In addition, the evolutionary conservation of mitochondrial Lon function is demonstrated by the ability of mouse Lon to substitute for the yeast protein in vivo.


Asunto(s)
Proteínas de Unión al ADN/genética , Proteínas de Choque Térmico/genética , Saccharomyces cerevisiae/genética , Serina Endopeptidasas/genética , Proteasas ATP-Dependientes , Adenosina Trifosfatasas/metabolismo , Secuencia de Aminoácidos , Animales , Células COS , Línea Celular , ADN Complementario/química , ADN Complementario/genética , Proteínas de Unión al ADN/metabolismo , Embrión de Mamíferos/metabolismo , Expresión Génica , Regulación del Desarrollo de la Expresión Génica , Prueba de Complementación Genética , Proteínas de Choque Térmico/metabolismo , Humanos , Masculino , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Mutación , Oligonucleótidos/metabolismo , Péptido Hidrolasas/metabolismo , Unión Proteica , ARN Mensajero/genética , ARN Mensajero/metabolismo , Saccharomyces cerevisiae/metabolismo , Alineación de Secuencia , Análisis de Secuencia de ADN , Homología de Secuencia de Aminoácido , Serina Endopeptidasas/metabolismo , Especificidad por Sustrato
7.
Invest Ophthalmol Vis Sci ; 54(8): 5471-80, 2013 Aug 13.
Artículo en Inglés | MEDLINE | ID: mdl-23847308

RESUMEN

PURPOSE: We examined whether baseline plasma levels of markers of inflammation and endothelial dysfunction are associated with the incidence of diabetic retinopathy (DR) in African Americans with type 1 insulin-dependent diabetes mellitus (T1DM). METHODS: At baseline and follow-up examinations, detailed ocular examination, structured clinical interview, venous blood specimens, and masked grading of seven standard field retinal photographs were obtained. Baseline plasma levels of 28 inflammatory biomarkers, measured using multiplex bead analysis system, were measured in the participants. RESULTS: After adjusting for age, glycemic control, and other potential confounders, baseline plasma levels of E-selectin were associated significantly with progression of DR, E-selectin and tumor necrosis factor-α (TNF-α) levels with incidence of proliferative DR (PDR), and soluble intercellular adhesion molecule-1 (sICAM-1) and TNF-α levels with incidence of macular edema (ME). CONCLUSIONS: In African Americans with T1DM, inflammation and endothelial dysfunction precede the development of DR, thus supporting the notion that inflammation may influence progression/incidence of disease.


Asunto(s)
Biomarcadores/sangre , Negro o Afroamericano , Diabetes Mellitus Tipo 1/sangre , Retinopatía Diabética/sangre , Inflamación/sangre , Adulto , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 1/etnología , Retinopatía Diabética/etnología , Retinopatía Diabética/etiología , Progresión de la Enfermedad , Humanos , Incidencia , Inflamación/complicaciones , Inflamación/etnología , Masculino , Pronóstico , Estudios Retrospectivos , Estados Unidos/epidemiología , Adulto Joven
8.
Infect Immun ; 74(4): 2015-21, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16552030

RESUMEN

Actinobacillus actinomycetemcomitans is the etiologic agent of localized aggressive periodontitis, a rapidly progressing oral disease that occurs in adolescents. A. actinomycetemcomitans can also cause systemic disease, including infective endocarditis. In early work on A. actinomycetemcomitans workers concluded that this bacterium is not beta-hemolytic. More recent reports have suggested that A. actinomycetemcomitans does have the potential to be beta-hemolytic. While growing A. actinomycetemcomitans on several types of growth media, we noticed a beta-hemolytic reaction on media from one manufacturer. Beta-hemolysis occurred on Columbia agar from Accumedia with either sheep or horse blood, but not on similar media from other manufacturers. A surprising result was that mutants of A. actinomycetemcomitans defective for production of leukotoxin, a toxin that is reportedly highly specific for only human and primate white blood cells, are not beta-hemolytic. Purified leukotoxin was able to lyse sheep and human erythrocytes in vitro. This work showed that in contrast to the accepted view, A. actinomycetemcomitans leukotoxin can indeed destroy erythrocytes and that the production of this toxin results in beta-hemolytic colonies on solid medium. In light of these results, the diagnostic criteria for clinical identification of A. actinomycetemcomitans and potentially related bacteria should be reevaluated. Furthermore, in studies on A. actinomycetemcomitans leukotoxin workers should now consider this toxin's ability to destroy red blood cells.


Asunto(s)
Aggregatibacter actinomycetemcomitans/fisiología , Exotoxinas/fisiología , Hemólisis/fisiología , Aggregatibacter actinomycetemcomitans/genética , Aggregatibacter actinomycetemcomitans/patogenicidad , Animales , Medios de Cultivo/metabolismo , Eritrocitos/metabolismo , Exotoxinas/genética , Exotoxinas/aislamiento & purificación , Hemólisis/genética , Humanos , Mutagénesis , Ovinos
9.
J Bacteriol ; 188(24): 8658-61, 2006 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17041062

RESUMEN

The gram-negative oral and systemic pathogen Aggregatibacter (Actinobacillus) actinomycetemcomitans produces a leukotoxin (LtxA) that is a member of the RTX (repeats in toxin) family of secreted bacterial toxins. We have recently shown that LtxA has the ability to lyse erythrocytes, which results in a beta-hemolytic phenotype on Columbia blood agar. To determine if LtxA is regulated by iron, we examined beta-hemolysis under iron-rich and iron-limiting conditions. Beta-hemolysis was suppressed in the presence of FeCl3. In contrast, strong beta-hemolysis occurred in the presence of the iron chelator deferoxamine. We found that secretion of LtxA was completely inhibited by free iron, but expression of ltxA was not regulated by iron. Free chromium, cobalt, and magnesium did not affect LtxA secretion. Other LtxA-associated genes were not regulated by iron. Thus, iron appears to play an important role in the regulation of LtxA secretion in A. actinomycetemcomitans in a manner independent of gene regulation.


Asunto(s)
Aggregatibacter actinomycetemcomitans/metabolismo , Exotoxinas/metabolismo , Regulación Bacteriana de la Expresión Génica , Hierro/metabolismo , Aggregatibacter actinomycetemcomitans/crecimiento & desarrollo , Animales , Toxinas Bacterianas/metabolismo , Medios de Cultivo , Eritrocitos , Hemólisis , Humanos , Ovinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA